Skip to main content

Table 2 Diagnostic tests for Legionnaires’ disease in 103 outbreak patients

From: Characterization of the extent of a large outbreak of Legionnaires’ disease by serological assays

Case definition

Laboratory test

No. positive/no. tested (%)

Additional (cumulative) no. of LD-cases

Comments

Confirmed LD (direct demonstration of Lp 1 infection)

Positive Lp 1 UAT*

52/99 (53)

52

 

Culture of Lp 1 (sputum)*

4/30 (13)

1 (53)

Pos. UAT : 3

Neg UAT: 1

Culture of Lp 1 (lung tissue)*

6/7 (86)

3 (56)

Pos UAT: 3

Neg UAT: 2

UAT not done: 1

Positive PCR

8/25 (32)

0 (56)

Sputum: 5/22

Lung tissue: 3/3

Confirmed LD** (serology)

≥4-fold titre change in IFA

40/84 (48)

25 (81)

13 patients had ≥4-fold titre change in IFA, but no seroconversion in ELISA.

IgM/IgG seroconversion in ELISA

30/84 (36)

6 (87)

Probable LD (single high or high standing antibody level)

IFA-titre ≥128

68/92 (74)

9 (96)

 

ELISA IgM ≥120 U/ml and/or IgG ≥50 U/ml

59/92 (64)

1 (97)

 

Probable LD (ELISA ratio ≥1.5)

ELISA IgM ratio ≥1.5 and/or IgG ratio ≥1.5

75/84 (89)

6 (103)

 
  1. LD: Legionnaires’ disease, Lp 1: L. pneumophila serogroup 1, UAT: urinary antigen test. The proportion of serogroup 1 specificity to the outbreak strain on immunoblots among the serologically confirmed and probable LD cases was similar (70%) to that of the culture, PCR, and/or UAT-confirmed LD cases.
  2. *Historical data [16]. Three of these patients were admitted to other hospitals in Norway and thus not shown in Figure 1.
  3. **One of these cases was admitted to another hospital and thus not shown in Figure 1.